A consortium including Continental Grain, Bunge and Tekfen has pushed the crop nutrition product developer's total funding to more than $186m.
US-based crop nutrition technology developer Pivot Bio completed a $100m series C round yesterday featuring industrial conglomerate Tekfen and commodity trading firms Bunge and Continental Grain. Energy technology investment fund Breakthrough Energy Ventures (BEV) and Singaporean state-owned firm Temasek co-led the round, which included DCVC, Prelude Ventures, Spruce Capital Partners, Codon Capital, Pavilion Capital and…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.